Pharmafile Logo
  • - PMLiVE
  • - PMLiVE
  • Diversity, Equity and Inclusion
  • Communiqué 53 Cover Image

B2B sales

Synergy Vision wins gold Investors in People accreditation

Agency upgraded from silver to gold status

- PMLiVE

Merck gains ground in lung cancer with first-line combo approval

Keytruda wins FDA backing for all first-line NSCLC patients

- PMLiVE

GSK’s Nucala posts mixed results in COPD

Conflicting late-stage trials throw doubt on its prospects

Sanofi targets patient literacy in clinical trials drive

Unveils new online resources for those in the US

- PMLiVE

Dirk Poschenrieder joins Havas Life Dusseldorf

Moves to the agency from Territory to be its new managing director

- PMLiVE

Here’s to all the bright sparks

‘Light bulb’ moments that changed healthcare forever

Stephen Eck joins Aravive Biologics

He takes up president and CEO positions

- PMLiVE

The Communiqué Awards at 20: Sarah Matthew

The president of Golin's global health practice on her long-standing association with the awards

- PMLiVE

INC Research to merge with InVentiv Health

Combined will be second-largest outsourcing provider after QuintilesIMS

- PMLiVE

Ashfield Healthcare Communications expands UK and Ireland presence

Opens new offices in Dublin and Glasgow

- PMLiVE

It’s time to shine for Lucid’s rare disease team

No team members were getting their hands dirty today! Instead, they were treated to car valets and manicures as a thank you for all their hard work delivering a number...

Lucid Group Communications Limited

AstraZeneca AZ

AZ trial adds to pessimism about anti-IL-13 asthma drugs

Firm's IL-13 inhibitor failed to reduce the number of asthma attacks compared to placebo

Subscribe to our email news alerts

Latest content

Latest intelligence

Quick links